[Safety data of the new, reduced-dose influenza vaccine FluArt after its first season on the market].
CONCLUSIONS: Based on the results, the authors conclude that the new, reduced dose vaccine FluArt is safe and tolerable. Orv Hetil. 2017; 158(49): 1953-1959.
PMID: 29199437 [PubMed - in process]
Source: Orvosi Hetilap - Category: General Medicine Authors: Vajó P, Gyurján O, Szabó ÁM, Kalabay L, Vajó Z, Torzsa P Tags: Orv Hetil Source Type: research
More News: Allergy & Immunology | European Medicines Agency (EMA) | General Medicine | Hungary Health | Influenza | Influenza Vaccine | Statistics | Study | Vaccines